APA (7th ed.) Citation

IT, R., V, G., KL, F., SL, G., C, B., Q, H., . . . MT, L. (2025). MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing. PLoS biology, 23(8), e3003308. https://doi.org/10.1371/journal.pbio.3003308

Chicago Style (17th ed.) Citation

IT, Raheem, et al. "MK-8527 Is a Novel Inhibitor of HIV-1 Reverse Transcriptase Translocation with Potential for Extended-duration Dosing." PLoS Biology 23, no. 8 (2025): e3003308. https://doi.org/10.1371/journal.pbio.3003308.

MLA (9th ed.) Citation

IT, Raheem, et al. "MK-8527 Is a Novel Inhibitor of HIV-1 Reverse Transcriptase Translocation with Potential for Extended-duration Dosing." PLoS Biology, vol. 23, no. 8, 2025, p. e3003308, https://doi.org/10.1371/journal.pbio.3003308.